<DOC>
	<DOCNO>NCT02700347</DOCNO>
	<brief_summary>The purpose study evaluate bactericidal activity Mycobacterium tuberculosis pyrazinamide combination allopurinol . Pharmacokinetics ( PK ) whole blood bactericidal activity ( WBA ) measure healthy volunteer follow administration pyrazinamide alone combination allopurinol .</brief_summary>
	<brief_title>Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis Pyrazinamide Plus Allopurinol Healthy Volunteers</brief_title>
	<detailed_description>The whole blood bactericidal activity ( WBA ) assay ex vivo model measure combined effect administer drug , host factor strain factor mycobacterial sterilisation . If perform parallel PK measurement , method use evaluate effect drug throughout dose cycle . The aim trial ass WBA activity PK data pyrazinamide metabolite boost allopurinol healthy volunteer .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Pyrazinamide</mesh_term>
	<criteria>1 . Aged 21 70 year old 2 . Male female willing comply study visit procedures 3 . Willing able provide write informed consent 1 . Women currently pregnant breastfeed 2 . Body weight 50kg 3 . HLAB*5801 allele positive 4 . Clinical evidence ( symptoms and/or sign ) suggestive active TB 5 . Previous hypersensitivity , intolerance allergy pyrazinamide allopurinol 6 . Current use drug medication know interaction pyrazinamide allopurinol , know antiTB activity 7 . Evidence renal hepatic dysfunction clinically significant deviation normal screen include laboratory determination 8 . Known hepatic disease ( include chronic hepatitis ) , recent hepatitis ( within last 6 month ) alcohol abuse 9 . Known hyperuricaemia evidence hyperuricaemia screen 10 . History current episode gout 11 . Any significant condition would , opinion investigator , compromise volunteer 's safety outcome trial 12 . Current participation clinical intervention trial research protocol</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>